Cathay International Holdings Limited

CTI

BMG1965E1030

Pharmaceuticals

Delayed London S.E. Other stock markets 11:35:03 2020-12-01 am EST			5-day change	1st Jan Change
0.75 ^GBX	-25.00%		-.--%	-78.57%

2023	Cathay International Holdings Limited completed the acquisition of additional 31.78% stake in Lansen Pharmaceutical Holdings Limited.	CI
2023	Cathay International Holdings Limited made an offer to acquire an additional 31.78% stake in Lansen Pharmaceutical Holdings Limited for HKD 240 million.	CI

Rights Issue: 16.7456 new shares @ 0.015 GBP for 1 existing share

April 26, 2020

Latest news about Cathay International Holdings Limited

Cathay International Holdings Limited completed the acquisition of additional 31.78% stake in Lansen Pharmaceutical Holdings Limited.	Dec. 14	CI
Cathay International Holdings Limited made an offer to acquire an additional 31.78% stake in Lansen Pharmaceutical Holdings Limited for HKD 240 million.	23-09-16	CI
Cathay International Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-28	CI
Cathay International Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-01	CI
Cathay International Holdings Limited Announces Increase in Shareholder Loan	19-12-27	CI
Cathay International Holdings Limited Announces Board Changes	19-12-20	CI
Cathay International Holdings Limited Agrees New Loan Facility for USD 23 Million from Cathay International	19-11-22	CI
Cathay International Holdings Limited Announces Retirement of Lee Jin Yi as CEO and Executive Director	19-10-31	CI
Cathay International Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-30	CI
Cathay International Holdings Limited Provides Trading Update for the Six Months Ended 30 June 2019	19-07-25	CI
Cathay International Holdings Limited Appoints Yiu Chi Hung as Company Secretary	19-06-12	CI
Cathay International Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2018	19-03-29	CI
Cathay International Holdings Limited Provides Earnings Guidance for the Year Ended December 31, 2018	19-01-25	CI
Cathay International Holdings Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2018	18-08-31	CI
Cathay International Holdings Limited Provides Earnings Guidance for the First Six Months Ended June 30, 2018 and for the Full Year of Fiscal 2018	18-07-13	CI
Cathay International Holdings Limited Reports Consolidated Earnings Results for the Year Ended December 31, 2017	18-04-08	CI
Cathay International Holdings Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2017	17-08-30	CI
Cathay International Holdings Limited Reports Consolidated Earnings Results for the Year Ended December 31, 2016	17-03-30	CI
Cathay International Holdings Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2016; Provides Earnings Guidance for the Year 2016	16-08-31	CI
Cathay International Holdings Ltd. Announces Appointment of Chan Ching Har Eliza as an Independent Non-Executive Director	16-04-05	CI
Cathay International Holdings Limited Reports Consolidated Earnings Results for the Year Ended December 31, 2015	16-03-30	CI
Cathay International Holdings Limited Revises Group Earnings Guidance for the Year Ending December 31, 2015	15-12-29	CI
Cathay International Holdings Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2015	15-08-28	CI
Tranche Update on Cathay International Holdings Limited's Equity Buyback Plan announced on April 9, 2015.	15-08-28	CI
Cathay International Holdings Limited Announces Board Changes	15-06-05	CI

Chart Cathay International Holdings Limited

Duration

Period

Chart Cathay International Holdings Limited

More charts

Cathay International Holdings Ltd is an investment holding company principally engaged in the healthcare business. The Company operates five business segments through its subsidiaries. The Lansen segment engages in the manufacture and sale of pharmaceuticals, cosmeceutical products and plant extracts and healthcare products. The Haizi segment produces inositol and its by-product, di-calcium phosphate. The Natural Dailyhealth segment is involved in the production and sales of plant extracts for use as active ingredients in health products. The Botai segment involves in the production and sales of collagen injectable fillers and development of collagen related products. The Hotel Operation segment operates a hotel.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CATHAY INTERNATIONAL HOLDINGS LIMITED	-78.57%	54.86M
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals

Cathay International Holdings Limited

Equities

CTI

BMG1965E1030

Pharmaceuticals

Rights Issue: 16.7456 new shares @ 0.015 GBP for 1 existing share

Latest news about Cathay International Holdings Limited

Chart Cathay International Holdings Limited

Company Profile

Sector Other Pharmaceuticals